Original Article
Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of Herpes Simplex Virus Types 1 and 2-United States, 1999-2010. J Infect Dis. 2014;209(3):325-333.
10.1093/infdis/jit458Zhang SY. Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity. Hum Genet. 2020;139(6-7):911-918.
10.1007/s00439-020-02127-532040615PMC7739442Tanaka M, Kagawa H, Yamanashi Y, Sata T, Kawaguchi Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol. 2003;77(2):1382-1391.
10.1128/JVI.77.2.1382-1391.200312502854PMC140785Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281-2308.
10.1038/nprot.2013.14324157548PMC3969860Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816-821.
10.1126/science.122582922745249PMC6286148Lin C, Li H, Hao M, Xiong D, Luo Y, Huang C, et al. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells. Sci Rep. 2016;6(1):34531.
10.1038/srep3453127713537PMC5054376López-Muñoz AD, Rastrojo A, Martín R, Alcami A. High-throughput engineering of cytoplasmic- and nuclear-replicating large dsDNA viruses by CRISPR/Cas9. J Gen Virol. 2022;103(10):001797.
10.1099/jgv.0.00179736260063PMC10019086Gurtu V, Yan G, Zhang G. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines. Biochem Biophys Res Commun. 1996;229(1):295-298.
10.1006/bbrc.1996.1795Desai PJ. A Null Mutation in the UL36 Gene of Herpes Simplex Virus Type 1 Results in Accumulation of Unenveloped DNA-Filled Capsids in the Cytoplasm of Infected Cells. J Virol. 2000;74(24):11608-11618.
10.1128/JVI.74.24.11608-11618.2000Wang S, Wang K, Li J, Zheng C. Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Inhibits Beta Interferon Production by Deubiquitinating TRAF3. J Virol. 2013;87(21):11851-11860.
10.1128/JVI.01211-1323986588PMC3807349Labun K, Montague TG, Krause M, Torres Cleuren YN, Tjeldnes H, Valen E. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 2019;47(W1):W171-W174.
10.1093/nar/gkz36531106371PMC6602426Liang X, Potter J, Kumar S, Ravinder N, Chesnut JD. Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J Biotechnol. 2017;241:136-146.
10.1016/j.jbiotec.2016.11.011Wang S, Wang K, Li J, Zheng C. Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Inhibits Beta Interferon Production by Deubiquitinating TRAF3. J Virol. 2013;87(21):11851-11860.
10.1128/JVI.01211-1323986588PMC3807349Bolstad M, Abaitua F, Crump CM, O’Hare P. Autocatalytic Activity of the Ubiquitin-Specific Protease Domain of Herpes Simplex Virus 1 VP1-2. J Virol. 2011;85(17):8738-51.
10.1128/JVI.00798-1121715485PMC3165783Bodda C, Reinert LS, Fruhwürth S, Richardo T, Sun C, Zhang BC, et al. HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection. J Exp Med. 2020;217(7):e20191422.
10.1084/jem.2019142232383759PMC7336311Zhou H, O’Neal W, Morral N, Beaudet AL. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. J Virol. 1996;70(10):7030-7038.
10.1128/jvi.70.10.7030-7038.19968794347PMC190753- Publisher :The Korean Society for Microbiology and The Korean Society of Virology
- Publisher(Ko) :대한미생물학회‧대한바이러스학회
- Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
- Volume : 55
- No :3
- Pages :258-269
- Received Date : 2025-06-28
- Revised Date : 2025-09-25
- Accepted Date : 2025-09-25
- DOI :https://doi.org/10.4167/jbv.2025.55.3.258
JOURNAL OF BACTERIOLOGY AND VIROLOGY
